NASDAQ · TKNO
Healthcare · Drug Manufacturers - Specialty & Generic
$7.36
Down-$0.73 (-9.02%)
Updated Nov 1, 2026, 6:04 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · TKNO
1M range · 0 trading sessions · Daily adjusted prices
TKNO does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning TKNO.
Company
Market Activity
Research & News
TKNO research
Company profile and research snapshot.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 13, 2026 | TD Cowen | Buy | — |
| Sep 17, 2026 | Jefferies | Buy | — |
| Aug 11, 2026 | BTIG | Buy | — |
| Aug 5, 2026 | Roth Capital | Buy | — |
| Jul 10, 2024 | Stephens & Co. | Overweight | — |
No generated briefing is available yet.
Yahoo · Oct 23, 2026
Alpha Teknova (TKNO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Benzinga · Oct 22, 2026
U.S. stock futures fell as Tesla dropped 5.4% despite beating Q3 estimates; NVE, Cypherpunk, Lam Research and others also declined premarket.
Yahoo · Oct 21, 2026
HOLLISTER, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the Company will report its financial results for the third quarter ended September 30, 2026, on Wednesday, November 4, 2026, following the close of market. Teknova will host a webcast and conference call on Wednesday, November
Benzinga · Oct 21, 2026
U.S. stocks rose Wednesday, led by Nasdaq (+1.06%) and tech. Thermo Fisher beat estimates and raised guidance; oil fell, gold edged higher.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning TKNO.
